Total Payments
$6,146
2024 Payments
$1,819
Companies
43
Transactions
354
Medicare Patients
4,841
Medicare Billing
$858,860
Payment Breakdown by Category
Food & Beverage$6,086 (99.0%)
Education$59.98 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,086 | 352 | 99.0% |
| Education | $59.98 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,134 | 88 | $0 (2024) |
| GlaxoSmithKline, LLC. | $625.24 | 29 | $0 (2024) |
| Amgen Inc. | $474.25 | 32 | $0 (2024) |
| Novo Nordisk Inc | $442.73 | 28 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $410.25 | 21 | $0 (2024) |
| Lilly USA, LLC | $323.76 | 20 | $0 (2024) |
| PFIZER INC. | $310.35 | 17 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $282.81 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $257.69 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $230.66 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,819 | 102 | Otsuka America Pharmaceutical, Inc. ($274.77) |
| 2023 | $1,034 | 60 | ABBVIE INC. ($242.83) |
| 2022 | $956.16 | 50 | ABBVIE INC. ($443.05) |
| 2021 | $822.51 | 53 | GlaxoSmithKline, LLC. ($272.89) |
| 2020 | $630.20 | 39 | GlaxoSmithKline, LLC. ($77.97) |
| 2019 | $883.16 | 50 | GlaxoSmithKline, LLC. ($170.29) |
All Payment Transactions
354 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.44 | General |
| 12/22/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: ANTIBIOTIC | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.78 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: ANTIBIOTIC | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $117.68 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,325 | 4,470 | $1.0M | $303,626 |
| 2022 | 28 | 1,548 | 4,260 | $1.0M | $297,213 |
| 2021 | 32 | 1,394 | 3,149 | $705,329 | $200,216 |
| 2020 | 18 | 574 | 1,263 | $205,096 | $57,806 |
Total Patients
4,841
Total Services
13,142
Medicare Billing
$858,860
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 75 | 667 | $219,443 | $67,970 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 825 | $215,325 | $66,962 | 31.1% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 82 | 319 | $140,679 | $38,742 | 27.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 112 | 786 | $117,900 | $32,979 | 28.0% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 71 | 323 | $102,068 | $29,367 | 28.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 58 | 389 | $47,069 | $11,917 | 25.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 103 | 103 | $28,531 | $11,673 | 40.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 46 | 57 | $33,288 | $11,102 | 33.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 122 | 133 | $27,797 | $9,078 | 32.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 40 | 146 | $20,294 | $4,293 | 21.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 31 | 145 | $14,500 | $3,866 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $10,320 | $2,587 | 25.1% |
| 99345 | Residence visit for new patient with high level of medical decision making, per day, if using time, at least 75 minutes | Office | 2023 | 16 | 16 | $8,736 | $2,182 | 25.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 56 | $5,600 | $1,802 | 32.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 13 | 13 | $5,330 | $1,613 | 30.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 25 | 34 | $6,800 | $1,177 | 17.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 116 | $8,700 | $1,124 | 12.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 45 | 68 | $3,672 | $1,081 | 29.4% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 24 | 25 | $5,000 | $958.21 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $2,700 | $957.60 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,378 | $927.07 | 21.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 18 | $1,944 | $555.24 | 28.6% |
| 90471 | Administration of vaccine | Office | 2023 | 32 | 38 | $1,520 | $458.37 | 30.2% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 24 | 26 | $1,092 | $207.34 | 19.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 16 | 29 | $580.00 | $30.06 | 5.2% |
About Dr. Nabil Keith, MD
Dr. Nabil Keith, MD is a Family Medicine healthcare provider based in Dawsonville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306032198.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nabil Keith, MD has received a total of $6,146 in payments from pharmaceutical and medical device companies, with $1,819 received in 2024. These payments were reported across 354 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,086).
As a Medicare-enrolled provider, Keith has provided services to 4,841 Medicare beneficiaries, totaling 13,142 services with total Medicare billing of $858,860. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Dawsonville, GA
- Active Since 09/14/2007
- Last Updated 11/27/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306032198
Products in Payments
- VRAYLAR (Drug) $734.78
- TRELEGY ELLIPTA (Drug) $588.77
- REXULTI (Drug) $457.78
- UBRELVY (Drug) $290.17
- NUZYRA (Drug) $282.81
- Otezla (Drug) $278.37
- JARDIANCE (Drug) $258.57
- Ozempic (Drug) $208.81
- LEQVIO (Drug) $173.35
- QULIPTA (Drug) $155.56
- KRYSTEXXA (Biological) $136.74
- Aimovig (Biological) $131.02
- MOUNJARO (Drug) $127.57
- SUNOSI (Drug) $100.63
- Prolastin-C Liquid (Biological) $92.16
- Wegovy (Drug) $87.39
- CHANTIX (Drug) $84.90
- Veozah (Drug) $82.11
- Hillrom - Cardiac Ambulatory Monitor (Device) $73.27
- Auvelity (Drug) $71.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dawsonville
Dr. Ramzi Ghosn, M.d, M.D
Family Medicine — Payments: $22,104
Family Medicine $22,104
Ernst Nieuwoudt, M.d, M.D
Family Medicine — Payments: $12,268
Family Medicine $12,268
Priya Shah, M.d, M.D
Family Medicine — Payments: $6,290
Family Medicine $6,290
Daniel Musser, Md, MD
Family Medicine — Payments: $3,425
Family Medicine $3,425
Dr. Katia Adams, M.d, M.D
Family Medicine — Payments: $3,068
Family Medicine $3,068
Dr. Larry Anderson, D.o, D.O
Family Medicine — Payments: $2,229
Family Medicine $2,229